is glp-1 bad Drugs for Weight Loss: The Good, and Unknown Exploring the Side Effects of
Description
For instance, randomized controlled trials comparing the coadministration of short- or long-acting GLP-1 RAs and basal insulin with basal insulin placebo were identified, and data about differences in HbA 1c , fasting plasma glucose, body weight, and adverse events were extracted
The combined use of GLP-1 and semaglutide in weight loss treatment, complemented by remote client monitoring, has proven to be a game changer for the healthcare community
Further, because the only large-scale trials of GLP-1 agonists have been conducted in obese or overweight study populations, we dont yet know if these drugs affect body composition in normal-weight individuals in an equivalent manner
Efficacy and safety of glucagon-like peptide 1 receptor agonists for the treatment of type 2 diabetes mellitus: a network meta-analysis
Navigating the shortage is hard, but finding GLP-1s shouldnt be
